Showing results (1-10 of 217) with videos related to
Sort By:
Pageof 22
Diabetes/Metabolism Research and Reviews|March 19, 2016
A model-based approach to sample size estimation in recent onset type 1 diabetesBrian N Bundy, Jeffrey P Krischer, Endocrinology, Diabetes & Metabolism|July 25, 2020
A quantitative measure of treatment response in recent-onset type 1 diabetesBrian N Bundy, Jeffrey P Krischer, Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 14, 2003
Combined-modality therapy of locally advanced cervical cancerPeter G RoseGynecologic Oncology Reports|July 31, 2024
Prolonged treatment of neuroendocrine carcinoma of the cervix with a PARP inhibitor based on next generation sequencingPeter G RoseGynecologic Oncology Reports|December 21, 2023
Response of low HER2-expressing ovarian carcinosarcoma to trastuzumab deruxtecan, a case reportPeter G RoseThe Oncologist|March 29, 2005
Pegylated liposomal doxorubicin: optimizing the dosing schedule in ovarian cancerPeter G RoseCancer Drug Resistance (Alhambra, Calif.)|July 8, 2022
Ovarian cancer recurrence: is the definition of platinum sensitivity modified by PARPi, bevacizumab or other intervening treatments? : a clinical perspectivePeter G RoseSeminars in Oncology Nursing|January 2, 2004
Chemotherapy for newly diagnosed and relapsed advanced ovarian cancerPeter G RoseDiabetes Care|May 28, 2020
C-Peptide Levels in Subjects Followed Longitudinally Before and After Type 1 Diabetes Diagnosis in TrialNetMagdalena M Bogun, Brian N Bundy, Robin S Goland, et al.Pageof 22